Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz
- 1 March 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (5) , 626-628
- https://doi.org/10.1097/00002030-200003310-00025
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimensAIDS, 1999
- Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapyAIDS, 1999
- Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavirAIDS, 1999
- Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individualsAIDS, 1998
- Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failureAIDS, 1998
- The antiviral effect of ritonavir and saquinavir incombination amongst HIV-infected adultsAIDS, 1998
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavirAIDS, 1997